CAMcheck

Posted: 21 October 2011

In Revivo Tea / M Low / 18020 (8 September 2011) the Directorate accepted the respondent’s voluntary undertaking to withdraw or amend its advertising in a manner that addresses the concerns raised by the complainant. The undertaking was accepted for the respondent’s advertising on its website www.revivotea.com which promoted the Revivo Herbal Tea. The issue related to certain testimonials used by the respondent, which made reference to the products effect on the user’s HIV status, their CD4 count and their viral load.

The complainant specifically identified the following examples, which the respondent undertook to remove: “I started using Revivo capsules after I found out I was HIV positive in October last year. In November I bought a bottle. After 3 bottles of one month supply I did a second test for cd4s and viral loads. In October my cd4 was 185 and viral loads was … Read the rest

Posted 06 July 2011

In Revivo Tea / P Linzer / 13898 (20 August 2009) the Directorate accepted the respondent’s voluntary undertaking to close the websites, www.herbalpharmacy.co.za and www.revivotea.co.za on condition that they were not used again in future. The Directorate also ruled that the respondent submitted no independent verification from a credible expert in this field to show that its product, as a whole, has any effect on HIV and AIDS. The ASA Directorate investigated the complaint as a possible breach of the previous ruling for ongoing ads being placed in the form of an “Ads by Google” below the editorial content.